Dr. Croot is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
911 Bypass Rd
Bldg A
Pikeville, KY 41501Phone+1 606-430-2212Fax+1 606-433-0638
Education & Training
University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002- University of Mississippi Medical CenterResidency, Internal Medicine/Pediatrics, 1995 - 1999
University of Kentucky College of MedicineClass of 1995
Certifications & Licensure
KY State Medical License 2015 - 2025
MS State Medical License 1996 - 2016
AL State Medical License 2003 - 2015- American Board of Internal Medicine Hematology
Clinical Trials
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC) Start of enrollment: 2014 Jul 01
- Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC Start of enrollment: 2017 Jun 29
Publications & Presentations
PubMed
- 241 citationsEffects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trialAdrian S. Dobs, Ralph V Boccia, Christopher Charles Croot, Nashat Y Gabrail, James T. Dalton
The Lancet. Oncology. 2013-04-01
Press Mentions
Leonard Lawson Cancer Center at PMCApril 30th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
